title: Withdrawing FDA approval of midodrine after marketing.
authors.forename: Neil A
authors.initials: NA
authors.lastname: Holtzman
authors.forename: Barbara
authors.initials: B
authors.lastname: Starfield
mesh_terms: D058646:Adrenergic alpha-1 Receptor Agonists / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D030881:Disclosure; D017277:Drug Approval; D004345:Drug Industry; D008879:Midodrine / Q000009:adverse effects*; D011358:Product Surveillance, Postmarketing / Q000592:standards*; D056737:Safety-Based Drug Withdrawals; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D058646:Adrenergic alpha-1 Receptor Agonists; D008879:Midodrine